Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

Molecular Biomarker Analyses Using Circulating Tumor Cells

(2010) Elizabeth A. Punnoose et al.   PLoS One

HER2 as marker for the detection of circulating tumor cells

(2009) Volkmar Müller et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

(2009) Anieta M. Sieuwerts et al.   BREAST CANCER RESEARCH AND TREATMENT

HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil

(2009) H. Korkaya et al.   CLINICAL CANCER RESEARCH

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Circulating tumor cells in breast cancer

(2009) Michail Ignatiadis et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

(2009) Nikolaos Xenidis et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

(2009) Howard I Scher et al.   LANCET ONCOLOGY

Cancer micrometastases

(2009) Klaus Pantel et al.   Nature Reviews Clinical Oncology

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

(2008) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH